Using nanoparticle-coated electrodes to improve gene editing for brain-computer interfaces
Nanoparticle Coated Microelectrode Arrays for Electrochemically Controlled Gene Editing at the Electrode Site
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11089529
This study is looking at new ways to make tiny brain-computer devices work better for people with limb loss or sensory issues by using special coatings to keep them effective for a longer time and reduce any irritation from the body’s immune system.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11089529 on ClinicalTrials.gov |
What this research studies
This research focuses on developing microelectrode arrays (MEAs) that are coated with nanoparticles to enhance their performance in brain-computer interfaces. These devices aim to help patients with limb loss or sensory deficits by providing stable and effective stimulation to neurons over long periods. The study investigates how to prevent the degradation of these electrodes and reduce inflammation caused by the body’s immune response, which can hinder their functionality. By exploring gene editing techniques, the research seeks to modify the immune response to improve the longevity and effectiveness of these implants.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with amputations or sensory deficits who may benefit from advanced prosthetic devices or sensory restoration technologies.
Not a fit: Patients who do not have limb loss or sensory impairments may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and long-lasting brain-computer interfaces that significantly improve the quality of life for patients with limb loss or sensory impairments.
How similar studies have performed: Previous research has shown promise in using gene therapy techniques to modify immune responses, indicating potential success for this novel approach.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILLIAMS, NATHANIEL P — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: WILLIAMS, NATHANIEL P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.